FDA to Review ANI’s Request for Cortrophin Gel Use & Amazon Care to Expand Into Healthcare Services episode artwork

EPISODE · Oct 15, 2021 · 8 MIN

FDA to Review ANI’s Request for Cortrophin Gel Use & Amazon Care to Expand Into Healthcare Services

from MS News & Perspectives · host MS News Today

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article, “FDA to Review ANI’s Request for Cortrophin Gel Use” and reads the column by Ed Tobias, MS Wire, “Amazon Care to Expand Company’s Reach Into Healthcare Services”.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.https://www.mayzent.com/?utm_source=changeinrms_url&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020 ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/

Episode metadata supplied by the publisher feed · Published Oct 15, 2021

Embed this episode

NOW PLAYING

FDA to Review ANI’s Request for Cortrophin Gel Use & Amazon Care to Expand Into Healthcare Services

0:00 8:19

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MS News & Perspectives?

This episode is 8 minutes long.

When was this MS News & Perspectives episode published?

This episode was published on October 15, 2021.

Can I download this MS News & Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!